Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5386_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
16 Мб
Скачать
☆
174
Nano Physical Pharmaceutics of Nanogel Delivery System
5.4.1.3 Affecting factors of nanogel swelling
The swelling of nanogels in aqueous solution is based on the degree of dissociation of functional groups and the hydration of
         
of nanogels (chemical structure of polymers, degree of cross­linking, charge density of electrolyte gels, etc.); (2) Environmental parameters, such as pH, ionic strength, temperature, composition of swelling medium, etc. [28].
The pH value of the medium: The pH value of the medium
          
dimensional network structure containing ionizable groups such as protein and cellulose. At a certain pH value, the groups
   
resulting electrostatic repulsion can promote the swelling process of gels. For anionic hydrogels, the side chain groups ionize when the pH of the medium is greater than its acidity dissociation constant (pKa), and gels swell. The cationic hydrogels ionize when the pH is less than pKa, promoting the swelling process. Using 2-hydroxyethyl methacrylate, methyl methacrylate or N-vinyl-2-pyrrolidone as comonomers, the equilibrium and dynamic swelling behaviors of hydrogels containing methacrylic acid or various acrylamide were studied. pH-sensitive gels with a wide range of expansion ratios can be obtained through a series of composition changes [29].
Solution ionic strength: Ionic strength also determines the swelling of polyelectrolyte nanogel. For example, the swelling
          
linker under high ionic strength, but when under low ionic strength,
        
The general rule is that the cross-linking ratio of the cross-linked gel will decrease when the number of cross-links increases [30].
Temperature: Under certain circumstances, the interactions
         
temperature, which can lead to swelling or collapse of the gel, so nanogel is temperature responsive. when the system is in equilibrium (limited swelling), the maximum swelling degree decreases with the increase of temperature. This is mainly
NPP of Nanogels in Drug Delivery
175
because the swelling process is exothermic, and the increase in temperature will lead to a decrease in the binding strength of the particles in nanogels, and the maximum swelling degree they can bear decreases.
Others: The aging degree and cross-linking degree of nanogels
       
aging nanogels are, the higher the degree of cross-linking and the lower the degree of swelling.
5.4.1.4 Thixotropy and desizing effect of nanogels
Subject to an external force, the network structure of nanogels will be destroyed, linear particles will be separated from each other, and the system will show liquidity. If the external force is removed and nanogel is left to stand for a period of time, particles re-cross-link into a network structure, which is called thixotropy. The mutual transformation between sols and nanogels can be repeated.
       
During the placement process, the properties of the nanogels are still changing. This phenomenon is called aging. Its manifestation is the desizing phenomenon, also known as dehydration. In other words, under the condition of basically not changing the principle form of hydrogels, it makes the arrangement more orderly through the contraction of the particles, and simultaneously squeezes some liquid out to produce the “sweating” phenomenon [31]. The syneresis of a gel can also be regarded as a process of
  
which is proportional to the concentration of the nanogels.
The swelling behavior of pH-sensitive gels is not only related to the composition of gels, but also related to external changes. For sensitive gels containing weak acid groups, such as polyacrylic acid (PAA) and polymethacrylic acid (PMAA), when the external pH is higher than pKa, gels swell. And for sensitive gels containing weak base groups, such as polydimethylaminoethyl methacrylate (PDMAEAM), polyvinylpyridine (PVP), etc., there are one or more volume phase change points.
176
Nano Physical Pharmaceutics of Nanogel Delivery System

5.4.2 In vivo Circulation of Nanogels

Drug-loaded nanogels need to circulate in the body to transport the drug to the target site (Fig. 5.3). Its circulation time and integrity are essential to prevent the drug from being rapidly eliminated by the body or degraded and metabolized. One of the most important barriers to realizing long circulation of nanogels is their opsonization, that is, it is readily cleared by organs of the monocyte macrophage system such as the spleen and liver.
          
their hydrophilicity and reduce their interaction with serum
          
weight, and density of the surface PEG of the nanogels. The softness and deformability of nanogels also help to avoid the

physiological conditions to pass through membrane pores that are many times smaller than their hydrodynamic diameter. The deformability of nanogels can be adjusted by changing the cross­linking density between particles and changing the size of the cross-linked parts, and the introduction of electrolytes into the hydrogel network can increase the gel swelling ratio.
According to the structure of the carrier, targeted behaviors
                
antigen or receptor expressed in the tissue or cell of the lesion
        
antibodies, cytokines, or ligand proteins on the surface of carriers.
                  
or organs in in vivo circulation. For example, the particle sizes of carriers reaching the human brain, bone marrow, and other tissues and cells must be less than 50 nm; nanoparticles of 100 nm–200 nm are easy to be internalized by phagocytes of reticuloendothelial system and accumulate in the liver and the spleen; carriers with a particle size larger than 1000 nm will
        
intercepted by the lungs and mainly concentrated in the lungs [32]. The last one is physical targeting, which mainly exploits
 
NPP of Nanogels in Drug Delivery
177
                   
targeted movement. Nanogels are usually too large to pass through tight junctions between normal endothelial cells, but they can
       
These sites have distinctive structural features, such as vascular leakage defects and loose connections, and enhanced permeability
               
prolonging the retention time at target sites and promoting cell uptake. Compared with non-targeted nanogels, ligand-mediated targeted nanogels are mainly distributed in highly expressed tissues, which can avoid excessive accumulation of gel at non-

Figure 5.3 In vitro carrier–drug complex formaon process (micelles and nanogels), microstructural parameters of complex properes, cellular interacon and intracellular fate. The physicochemistry parameters noted
here are also shown in Fig. 1.16 in Chapter 1.
After the nanogel is extravasated from blood vessels, it
        
and can be absorbed by target cells through various endocytosis
178
Nano Physical Pharmaceutics of Nanogel Delivery System
mechanisms, according to the surface characteristics of nanogels, such as size, softness and charge, as well as the receptor type of target cells. In general, nanogels enter endosomes via endocytosis and then reach lysosomes. The low pH, high degradation enzyme concentration, and reductive environment become the stimulating factors to drug release behavior from gels, giving them the


5.4.3 Drug Release Behavior of Nanogels

The loading, transportation, and release process of drugs through nanogels generally involves the following steps: (1) Dissolve nanogels in the drug solution. (2) Because of the concentration
        
the surface of nanogels. (3) The drug is desorbed from polymers
          
or tissues. During the whole process, there are many complex physical and chemical phenomena, and the release characteristics of drugs depend on the interaction of these physical and chemical phenomena [33]. Through the analysis of these phenomena and the study of the kinetic and thermodynamic process involved, a way to control and adjust the release rate of drugs can be found, so that the release of drugs from preparations can meet the expected requirements.
       
between reticular polymer chains to achieve drug release behavior. For degradable drug-loaded nanogels, the release of the drug is also related to the degradation rate of the polymer/chemical bonds. Biological agents can often be combined with nanogels through physical embedding and covalent binding. According to the loading method of the drug, this type of gel can be divided into
                
the polymer; the second one is to bond the drug on a polymer chain and the release of drug can be regulated by controlling the
       
polymer degradation mechanisms, the drug release behavior is

NPP of Nanogels in Drug Delivery
179
 r 
(1/ n1)
D
gel
D
1e
(5.13)
solution
z
where D
solution

r is the size of a drug molecule, z is the dynamic correlation length, or the mesh size between two cross-linking points, and
The drug release behavior of carriers mainly hinges on the interaction of the drug, the carrier, and the release medium. If the binding force between the carrier and the drug is greater than that between the carrier and medium, then the drug release is mainly decided by the degradation mechanism, and its release rate is

on the contrary, if the drug release behavior is dominated by

When the drug is bonded to the carrier material in the adsorption manner, the release of the drug is a desorption process and sudden release is easy to occur. For poorly soluble drugs, the release process in some cases is controlled by the solvation process of the
  
drug-loading system, the release of the drug may be based mainly on one mechanism and secondarily on multiple other mechanisms;
 
stages. For polymer nanoparticles, the multiphase release pattern often appears, including the initial burst release period and the subsequent sustained release period.

by its microstructure [34], and how to overcome the lack of drug release is an important problem in drug delivery systems. Wei Li’s [35] group studied a novel dual-controlled temperature­sensitive nanogel to improve drug release, and drug release
        
by the microstructure of nanogels. Therefore, establishing the
     D
) inside
gel
the gel and the microstructure change during the phase transition of nanogels contributes to the improvement of drug release behavior. This relationship can be explained by the following equation:
180
Nano Physical Pharmaceutics of Nanogel Delivery System
n is the volume swelling rate of the nanogels (n = V
swell
)/(V
collapse
).       z and n. As shown in Fig. 5.8, when the temperature causes a phase transition, the uneven collapse will cause a dense surface layer. Due to high chain entanglement or overlap, z and n are relatively small and the diameter in the collapse state is about 90 nm. Both z and n are able to lead to a decrease in D
gel
, which indicates that the
        
irradiation, z and n are larger, and D
gel
is therefore larger (Fig. 5.4),
which means a large drug release (Q) and well explains the drug

Figure 5.4 The eects of structural collapse and microstructure (mesh size) of the temperature-sensive nanogels during the phase transion process on the drug release, which is described by the modied drug release funcon shown in 5.13.

5.4.4 Factors Affecting the Release of Drug-Loaded Nanogels

When the nanogel drug delivery system reaches the diseased tissue or cell, how to control the release and the releasing dose is a key issue. The network of nanogel is sensitive to the environment, can withstand rapid changes in volume, and can be stimulated to control the release of bioactive compounds. In
        
delivery and release of the targeted drug. According to whether the system responds to the signal or not, the release of nanogels
NPP of Nanogels in Drug Delivery
181
can be divided into the programmed pulsed-release system (PPRS) and the intelligent pulsed-release system (IPRS). The release manner of PPRS is achieved through the pre-designed structure of the carrier, and the lag time and duration of drug release behavior are controlled by the polymer degradation performance. Butun et al. designed a release system similar to the core–shell type. The system consists of alternate drug-containing and drug-

duration, release time, and pulse number of drugs are determined by the composition and layered thickness of ossein [36]. IPRS requires external stimuli and the response of carriers. The intelligent drug pulse release system can be divided into external regulation and self-regulation according to the source of the signals. The former is the release of drugs regulated by external factors such as light, electricity and magnetism, while the latter realizes the drug release behavior through the system itself stimulated by pathological tissues. See the next section for details.
5.4.4.1 Drug-loading methods
             
drugs. The strategy and the process of drug loading are crucial for the release of the system. The calcium pectate nanogels prepared by the mixing method were faster in drug release behavior than the adsorption method or the swelling method, and the release time was shorter by 50%. The hydrogel prepared by Mackiewicz M. based on poly (N-isopropyl acrylamide) has improved in multiple properties [37]. First, cystine(BISS)acrylic derivative containing carboxyl group is used to replace the commonly used N,N-bis(acryloyl)cystamine (BAC) as the cross-linking agent, giving hydrogel particles better stability
       
including drug molecule bonding. Second, the water precipitation polymerization method, by using the semi-batch method to initiate redox, greatly increases the content of BISS and reduces the size of nanoparticles, which is conducive to endocytosis. In addition, the prepared nanogels show a higher loading capacity than dry nanogels (16%), showing better stability and enhanced drug

182
Nano Physical Pharmaceutics of Nanogel Delivery System
5.4.4.2 Medium pH
When anion or cationic groups that can be protonated or deprotonated are included in the 3D network of nanogels, their pH response to the medium is more sensitive. If the pH of the
        
these groups will change, leading to the change in hydrophilicity
      
gel. Anionic nanogels generally contain sulfonic or carboxylic acid groups, and if the pKa of the polymer is greater than the pH value of the solvent, its ionic structure results in an increase in electrostatic repulsion within the network and eventually leads to overall expansion. On the other hand, cationic nanogels generally contain amino groups at the end, so when the pH value of the environment around the gel is less than pKb, the amino
groups change from NH2 to charged NH3 group, thus its electrostatic repulsion, hydrophilicity and expansion rate are increased [39, 40]. The pH of healthy tissue (pH 7.4) and tumor
         
collapse of gel caused by the protonation or deprotonation of
      
be controlled.
5.4.4.3 Solvent
Nanogels work by loading hydrophobic drugs into polymer nanonetworks in a solvent, and the details of this process can have a profound impact on their properties. Earlier work [41, 42] showed that when nanoparticles were in an aqueous solvent,
         
hydrophobic core reorganizing into approximately spherical and dense regions, while the hydrophilic parts remained solvated.

but polymer nanoparticles may adopt conformations unfavorable for drug loading. Therefore, in the process of drug loading,
  
solvents, such as tetrahydrofuran, which is conducive to the formation of hydrophobic cores of nanoparticles [43]. Since the
        
by solvents, the particulars of the loading process, especially the
NPP of Nanogels in Drug Delivery
183
     
       
tetrahydrofuran and dimethylsulfoxide on the conformations of two kinds of nanogels were studied by simulating real full-
    
tetrahydrofuran and toluene are used in the drug-loading step, star polymer nanogels can load large drug molecules inside and the drug-loading rate rises. However, the use of methanol mainly leads to shallow or surface drug loading, so the drug release rate is higher. Ether cannot be used as solvent because it cannot

5.4.4.4 Particle size
  
loading and drug release capacity. Researchers have investigated the morphology, particle size and sustained release properties of a drug-loaded nanogel, in which polymethacrylic acid (PMAA) is the raw material, ethylene glycol dimethacrylate (EGDMA) is the cross-linker and amoxicillin (AM) is loaded. All the samples showed uniform spherical shape, and the particle sizes were less than 500 nm. In addition, the particle sizes of nanogels decreased with the increase in the content of the chain terminator (EGDMA). Further, the nanogels can achieve prolonged drug release, which indicates that nanogels can control and continuously release drugs and have long-term antimicrobial activity [46].
           
the decrease in particle size. This may be because smaller nanogel particles form a denser hydrogel network, hindering the release of drugs from the nanogels.
5.4.4.5 Surface charge
The existence of electrolytes in suspension is crucial for the charged nanogel in aqueous medium. In fact, moving ions are distributed in and around the porous nanogel, forming a so­called electric bilayer, which may determine the degree of particle
  